Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 07/31/08
End: 09/30/09
Due: 09/30/10
Phase: N/A
Priority: Normal
Start: 09/30/09
End: 09/30/12
Due: 09/30/13
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Phase 2a Study to Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of AG011 in Ulcerative Colitis | NCT00729872 | ActoGeniX N.V. | user2@example.com | None | 2008-07-31 | 2009-09-30 | 2010-09-30 | - | - | 2025-07-14 |
| Study to Assess Safety and Tolerability of AG013 in Oral Mucositis in Subjects Receiving Induction Chemotherapy for the Treatment of Cancers of the Head and Neck | NCT00938080 | ActoGeniX N.V. | user2@example.com | None | 2009-09-30 | 2012-09-30 | 2013-09-30 | - | - | 2025-07-14 |